Bristol buying out Axion stake in Oncology Therapeutics Network joint venture.
BRISTOL TO BUY OUT ONCOLOGY THERAPEUTICS NETWORK JOINT VENTURE from co-owner Axion, a San Bruno, Calif.-based oncology specialty firm, BMS announced Aug. 5. Bristol-Myers Squibb bought a 50% interest in Oncology Therapeutics Network in 1993. Axion founded its physician-office oncology product distribution business in 1990.
You may also be interested in...
Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011